Considerations for RT-qPCR in molecular point of care testing devices

Considerations for RT-qPCR in molecular point of care testing devices

The COVID-19 pandemic has accelerated the uptake of point of care testing (POCT), with simple, user-administered tests becoming commonplace in schools, places of work and people’s homes. Antigen POCT has been pivotal in SARS-CoV-2 detection, particularly where reverse transcription PCR (RT-PCR) cannot be delivered in a timely manner. However, the use of antigen tests isn’t always appropriate due to variable sensitivity. RT-PCR – or RT-qPCR if using real-time detection – offers greater sensitivity and specificity. Leveraging this technology in POCT brings lab quality results to the point of need, providing rapid, accurate and actionable results to clinicians.

Read more

The BiosearchTech Blog

Most popular

Optimising automated high-throughput pathogen detection workflows

Posted on Wed, Mar 30, 2022 @ 09:00 AM

While both centralised and decentralised molecular diagnostics (MDx) testing models play an important role in patient ...
Read more

Topics: Molecular Diagnostics, qPCR, High-Throughput, Point of care testing

Improving the sustainability of oil palm breeding programmes using marker-assisted selection

Posted on Tue, Mar 08, 2022 @ 01:00 PM

African oil palm (Elaeis guineensis Jacq.) is a highly productive perennial crop that is used widely in food, ...
Read more

Topics: Agrigenomics, Genotyping, High-Throughput, Genomic Selection

Increasing hybrid rice breeding efficiency with high-throughput genotyping

Posted on Tue, Jan 18, 2022 @ 01:03 PM

Rice is the primary staple for more than half the world's population.1 With so many people relying on the crop for ...
Read more

Topics: Agrigenomics, Genotyping, High-Throughput, Crop Breeding

Can COVID-19 testing be made more sustainable during prolonged uncertainty?

Posted on Mon, Sep 27, 2021 @ 12:36 PM

In September 2021, Delta persists as the most prevalent variant worldwide1 due to its high infectivity, causing surges ...
Read more

Topics: Molecular Diagnostics, High-Throughput, SARS-CoV-2

It’s official! Personal Health becomes first China demonstration laboratory site for LGC’s Nexar System

Posted on Wed, May 03, 2017 @ 07:05 AM

LGC's Genomics Division has signed a memorandum of understanding (MOU) with Chinese health management expert Personal ...
Read more

Topics: Announcement, Genomics, High-Throughput

Subscribe to our blog

About LGC, Biosearch Technologies

LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!